-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U2W77vyoVGRBG4//Mmc1Qzfy7zdyRcTJoQuqUVaDH417QT3kAKqMYFiXRINUp3a/ LNWyLEPBjph2HBGDv43ANA== 0000109657-06-000048.txt : 20060802 0000109657-06-000048.hdr.sgml : 20060802 20060802185633 ACCESSION NUMBER: 0000109657-06-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060801 FILED AS OF DATE: 20060802 DATE AS OF CHANGE: 20060802 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6502122568 MAIL ADDRESS: STREET 1: 323 VINTAGE PARK DRIVE, SUITE B CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REPINE JOHN E CENTRAL INDEX KEY: 0001067191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 06999417 BUSINESS ADDRESS: BUSINESS PHONE: 3036501200 MAIL ADDRESS: STREET 1: 6850 N BROADWAY SUITE G CITY: DENVER STATE: CO ZIP: 80221 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-08-01 0 0000109657 OXIS INTERNATIONAL INC OXIS.OB 0001067191 REPINE JOHN E 70 CHERRY HILLS FARM DRIVE ENGLEWOOD CO 80113 1 0 0 0 Non-Qualified Stock Option 0.27 2006-08-01 2006-08-01 4 A 0 5000 0 A 2007-08-01 2016-07-31 Common Stock 5000 67400 D Michael D. Centron, Attorney-in-fact for John E. Repine 2006-08-02 -----END PRIVACY-ENHANCED MESSAGE-----